You just read:

Immune Pharmaceuticals Signs Agreement to Fund Maxim Pharmaceuticals, Inc., its Pain and Neurology subsidiary

News provided by

Immune Pharmaceuticals Inc.

16 Sep, 2016, 07:30 ET